NCT06050850

Brief Summary

The purpose of this study is to conduct a single arm pilot of the NOURISH-ALL (Nourishing Our Understanding of Role modeling to Improve Support and Health in Acute Lymphoblastic Leukemia) intervention focused on three components of participant engagement. This is a single arm intervention study that involves participation in a 6-session family intervention and three time points of multimethod data collection. The primary outcome is participant engagement, measured as recruitment, retention, and intended dose received. This study will be conducted over 5 years in three phases:

  • Aim 1a: Adapting the NOURISH-ALL Intervention for Families of Youth with ALL (Year 1)
  • Aim 1b: Iteratively Refining the NOURISH-ALL Intervention (Year 2)
  • Aim 2: Pilot Single-Arm Trial of NOURISH-ALL Focused on Participant Engagement (Years 3-5)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
42mo left

Started Oct 2023

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Oct 2023Oct 2029

First Submitted

Initial submission to the registry

September 8, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 22, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

October 17, 2023

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2029

Last Updated

October 24, 2025

Status Verified

October 1, 2025

Enrollment Period

5 years

First QC Date

September 8, 2023

Last Update Submit

October 22, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Recruitment Rate

    Measured by # enrolled / # eligible

    Baseline (Week 0)

  • Retention Rate

    Measured by # completed intervention / # enrolled

    Post-Intervention (Week 6), Follow-Up (Month 6)

  • Intended dose received

    Measured by # sessions attended / # sessions offered

    Post-Intervention (Week 6), Follow-Up (Month 6)

Secondary Outcomes (9)

  • Child Body Mass Index (BMI)

    Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  • Child Physical Activity

    Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  • Child Sleep

    Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  • Child Dietary Intake

    Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  • Family Stress Measures

    Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  • +4 more secondary outcomes

Study Arms (3)

Aim 1a: Adapting the NOURISH-ALL Intervention for Families of Youth with ALL (Year 1)

The purpose of Aim 1a is to adapt the NOURISH-T intervention to meet the specific needs of families during the early phases of ALL treatment. To achieve this goal, the study will initiate a three-step intervention adaptation process that includes (1) initial integration of cognitive behavioral therapy (CBT) and family systems frameworks, (2) formative assessment with families of youth with ALL, and (3) formative assessment with multidisciplinary experts.

Aim 1b: Iteratively Refining the NOURISH-ALL Intervention (Year 2)

The purpose of Aim 1b is to adaptively refine NOURISH-ALL through sequential testing with individual families during the early phases of ALL treatment, with the goal of optimizing feasibility and acceptability from the family perspective. In line with the ORBIT model, the study will utilize an adaptive approach, similar to the commonly known "PDSA cycle," to maximize responsivity to individual patient/family feedback. Participants will receive NOURISH-ALL and provide feedback throughout the intervention (i.e., after each session and upon intervention completion), which will be iteratively analyzed and incorporated to improve intervention delivery for the next family

Behavioral: NOURISH-ALL

Aim 2: Pilot Single-Arm Trial of NOURISH-ALL Focused on Participant Engagement (Years 3-5)

Pilot testing key components of engagement is critical to optimizing design and methodology of fully powered efficacy trials. The purpose of Aim 2 is to pilot a single-arm trial of the finalized NOURISH-ALL intervention in a sample of families of youth in the early phases of ALL treatment to assess recruitment, retention, and dose received. Results will directly inform the design of the fully powered randomized control trial to test intervention efficacy (R01 application to be submitted in Year 4).

Behavioral: NOURISH-ALL

Interventions

NOURISH-ALLBEHAVIORAL

Our NOURISH-ALL intervention will build on this existing NOURISH-T family based behavioral intervention with families of cancer survivors. The intervention, NOURISH-ALL, will adapt these family-based health promotion strategies to the early ALL treatment context.

Aim 1b: Iteratively Refining the NOURISH-ALL Intervention (Year 2)Aim 2: Pilot Single-Arm Trial of NOURISH-ALL Focused on Participant Engagement (Years 3-5)

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Families of youth aged 2-12 years who are newly diagnosed with acute lymphoblastic leukemia.

You may qualify if:

  • Children ages 2-12 years old and their primary caregiver ages 18-90
  • Child diagnosed with acute lymphoblastic leukemia (ALL)
  • Child completed induction phase of therapy and not yet in maintenance phase of therapy
  • Primary caregiver and child English language proficient
  • Primary caregiver able to provide permission for child to participate in research
  • Primary caregiver identifies as being involved with child's oncology care
  • Primary caregiver lives with child at least 50% of the time
  • Primary oncology provider confirms child is eligible to participate

You may not qualify if:

  • Primary oncology provider identifies safety concerns regarding the child's participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

ACTIVE NOT RECRUITING

Children's Mercy Kansas City

Kansas City, Missouri, 64118, United States

RECRUITING

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-LymphomaHealth Behavior

Condition Hierarchy (Ancestors)

Leukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesBehavior

Study Officials

  • Carolyn Bates, PhD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR
  • Keith August, MD

    Children's Mercy Kansas City

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Carolyn Bates, PhD

CONTACT

Kelsey M Dean

CONTACT

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Assistant Professor

Study Record Dates

First Submitted

September 8, 2023

First Posted

September 22, 2023

Study Start

October 17, 2023

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

October 1, 2029

Last Updated

October 24, 2025

Record last verified: 2025-10

Locations